1
|
Yakushev A, Lens L, Düllmann CE, Khuyagbaatar J, Jäger E, Krier J, Runke J, Albers HM, Asai M, Block M, Despotopulos J, Di Nitto A, Eberhardt K, Forsberg U, Golubev P, Götz M, Götz S, Haba H, Harkness-Brennan L, Herzberg RD, Heßberger FP, Hinde D, Hübner A, Judson D, Kindler B, Komori Y, Konki J, Kratz J, Kurz N, Laatiaoui M, Lahiri S, Lommel B, Maiti M, Mistry AK, Mokry C, Moody KJ, Nagame Y, Omtvedt JP, Papadakis P, Pershina V, Rudolph D, Samiento L, Sato T, Schädel M, Scharrer P, Schausten B, Shaughnessy DA, Steiner J, Thörle-Pospiech P, Toyoshima A, Trautmann N, Tsukada K, Uusitalo J, Voss KO, Ward A, Wegrzecki M, Wiehl N, Williams E, Yakusheva V. On the adsorption and reactivity of element 114, flerovium. Front Chem 2022; 10:976635. [PMID: 36092655 PMCID: PMC9453156 DOI: 10.3389/fchem.2022.976635] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2022] [Accepted: 07/19/2022] [Indexed: 12/01/2022] Open
Abstract
Flerovium (Fl, element 114) is the heaviest element chemically studied so far. To date, its interaction with gold was investigated in two gas-solid chromatography experiments, which reported two different types of interaction, however, each based on the level of a few registered atoms only. Whereas noble-gas-like properties were suggested from the first experiment, the second one pointed at a volatile-metal-like character. Here, we present further experimental data on adsorption studies of Fl on silicon oxide and gold surfaces, accounting for the inhomogeneous nature of the surface, as it was used in the experiment and analyzed as part of the reported studies. We confirm that Fl is highly volatile and the least reactive member of group 14. Our experimental observations suggest that Fl exhibits lower reactivity towards Au than the volatile metal Hg, but higher reactivity than the noble gas Rn.
Collapse
Affiliation(s)
- A. Yakushev
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
- *Correspondence: A. Yakushev,
| | - L. Lens
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - Ch. E. Düllmann
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - J. Khuyagbaatar
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
| | - E. Jäger
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - J. Krier
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - J. Runke
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - H. M. Albers
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - M. Asai
- Japan Atomic Energy Agency, Tokai, Japan
| | - M. Block
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - J. Despotopulos
- Lawrence Livermore National Laboratory, Livermore, CA, United States
| | - A. Di Nitto
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - K. Eberhardt
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | | | | | - M. Götz
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - S. Götz
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | | | | | | | - F. P. Heßberger
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
| | - D. Hinde
- Australian National University, Canberra, ACT, Australia
| | - A. Hübner
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - D. Judson
- University of Liverpool, Liverpool, United Kingdom
| | - B. Kindler
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | | | - J. Konki
- University of Jyväskylä, Jyväskylä, Finland
| | - J.V. Kratz
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - N. Kurz
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - M. Laatiaoui
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - S. Lahiri
- Saha Institute of Nuclear Physics, Kolkata, India
| | - B. Lommel
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - M. Maiti
- Indian Institute of Technology Roorkee, Roorkee, India
| | - A. K. Mistry
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
| | - Ch. Mokry
- Helmholtz-Institut Mainz, Mainz, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - K. J. Moody
- Lawrence Livermore National Laboratory, Livermore, CA, United States
| | - Y. Nagame
- Japan Atomic Energy Agency, Tokai, Japan
| | | | - P. Papadakis
- University of Liverpool, Liverpool, United Kingdom
| | - V. Pershina
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | | | | | - T.K. Sato
- Japan Atomic Energy Agency, Tokai, Japan
| | - M. Schädel
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - P. Scharrer
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - B. Schausten
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - D. A. Shaughnessy
- Lawrence Livermore National Laboratory, Livermore, CA, United States
| | - J. Steiner
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - P. Thörle-Pospiech
- Helmholtz-Institut Mainz, Mainz, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | | | - N. Trautmann
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - K. Tsukada
- Japan Atomic Energy Agency, Tokai, Japan
| | | | - K.-O. Voss
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - A. Ward
- University of Liverpool, Liverpool, United Kingdom
| | - M. Wegrzecki
- Łukasiewicz Research Network—Institute of Electron Technology, Warsaw, Poland
| | - N. Wiehl
- Helmholtz-Institut Mainz, Mainz, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - E. Williams
- Australian National University, Canberra, ACT, Australia
| | - V. Yakusheva
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
| |
Collapse
|
2
|
Yakushev A, Lens L, Düllmann CE, Block M, Brand H, Calverley T, Dasgupta M, Di Nitto A, Götz M, Götz S, Haba H, Harkness-Brennan L, Herzberg RD, Heßberger FP, Hinde D, Hübner A, Jäger E, Judson D, Khuyagbaatar J, Kindler B, Komori Y, Konki J, Kratz J, Krier J, Kurz N, Laatiaoui M, Lommel B, Lorenz C, Maiti M, Mistry A, Mokry C, Nagame Y, Papadakis P, Såmark-Roth A, Rudolph D, Runke J, Sarmiento L, Sato T, Schädel M, Scharrer P, Schausten B, Steiner J, Thörle-Pospiech P, Toyoshima A, Trautmann N, Uusitalo J, Ward A, Wegrzecki M, Yakusheva V. First Study on Nihonium (Nh, Element 113) Chemistry at TASCA. Front Chem 2021; 9:753738. [PMID: 34917588 PMCID: PMC8669335 DOI: 10.3389/fchem.2021.753738] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2021] [Accepted: 10/27/2021] [Indexed: 11/13/2022] Open
Abstract
Nihonium (Nh, element 113) and flerovium (Fl, element 114) are the first superheavy elements in which the 7p shell is occupied. High volatility and inertness were predicted for Fl due to the strong relativistic stabilization of the closed 7p 1/2 sub-shell, which originates from a large spin-orbit splitting between the 7p 1/2 and 7p 3/2 orbitals. One unpaired electron in the outermost 7p 1/2 sub-shell in Nh is expected to give rise to a higher chemical reactivity. Theoretical predictions of Nh reactivity are discussed, along with results of the first experimental attempts to study Nh chemistry in the gas phase. The experimental observations verify a higher chemical reactivity of Nh atoms compared to its neighbor Fl and call for the development of advanced setups. First tests of a newly developed detection device miniCOMPACT with highly reactive Fr isotopes assure that effective chemical studies of Nh are within reach.
Collapse
Affiliation(s)
- A. Yakushev
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
| | - L. Lens
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - Ch. E. Düllmann
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - M. Block
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - H. Brand
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - T. Calverley
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - M. Dasgupta
- Department of Nuclear Physics, Australian National University, Canberra, ACT, Australia
| | - A. Di Nitto
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - M. Götz
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - S. Götz
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | | | | | - R-D. Herzberg
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - F. P. Heßberger
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
| | - D. Hinde
- Department of Nuclear Physics, Australian National University, Canberra, ACT, Australia
| | - A. Hübner
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - E. Jäger
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - D. Judson
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - J. Khuyagbaatar
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
| | - B. Kindler
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | | | - J. Konki
- Department of Physics, University of Jyväskylä, Jyväskylä, Finland
| | - J.V. Kratz
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - J. Krier
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - N. Kurz
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - M. Laatiaoui
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
| | - B. Lommel
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | | | - M. Maiti
- Indian Institute of Technology Roorkee, Roorkee, India
| | - A.K. Mistry
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
| | - Ch. Mokry
- Helmholtz-Institut Mainz, Mainz, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - Y. Nagame
- Japan Atomic Energy Agency, Tokai, Japan
| | - P. Papadakis
- Department of Physics, University of Jyväskylä, Jyväskylä, Finland
| | | | - D. Rudolph
- Department of Physics, Lund University, Lund, Sweden
| | - J. Runke
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | | | - T.K. Sato
- Japan Atomic Energy Agency, Tokai, Japan
| | - M. Schädel
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - P. Scharrer
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - B. Schausten
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - J. Steiner
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - P. Thörle-Pospiech
- Helmholtz-Institut Mainz, Mainz, Germany
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | | | - N. Trautmann
- Johannes Gutenberg-Universität Mainz, Mainz, Germany
| | - J. Uusitalo
- Department of Physics, University of Jyväskylä, Jyväskylä, Finland
| | - A. Ward
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - M. Wegrzecki
- Łukasiewicz-Instytut Mikroelektroniki I Fotoniki, Warsaw, Poland
| | - V. Yakusheva
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Helmholtz-Institut Mainz, Mainz, Germany
| |
Collapse
|
3
|
Ohlmann C, Roger Z, Rüssel C, Hellmis E, Suttmann H, Janssen M, Hübner A, Dahm J, Gleißner J, Scheffler M, Feyerabend S, Telle J, Klier J. Abiraterone acetate plus prednisone and LHRH therapy versus abiraterone acetate plus prednisone while sparing LHRH therapy in patients with progressive, metastatic and chemotherapy-naïve, castration-resistant prostate cancer: Results from the SPARE-trial (NCT02077634). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy284.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
4
|
Kölling M, Genschel C, Kaucsar T, Hübner A, Rong S, Schmitt R, Sörensen-Zender I, Haddad G, Kistler A, Seeger H, Kielstein JT, Fliser D, Haller H, Wüthrich R, Zörnig M, Thum T, Lorenzen J. Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injury. Sci Rep 2018; 8:3438. [PMID: 29467431 PMCID: PMC5821887 DOI: 10.1038/s41598-018-21720-3] [Citation(s) in RCA: 54] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2017] [Accepted: 02/09/2018] [Indexed: 12/27/2022] Open
Abstract
Renal ischemia-reperfusion (I/R) injury is a major cause of acute kidney injury (AKI). Non-coding RNAs are crucially involved in its pathophysiology. We identified hypoxia-induced long non-coding RNA Malat1 (Metastasis Associated Lung Adenocarcinoma Transcript 1) to be upregulated in renal I/R injury. We here elucidated the functional role of Malat1 in vitro and its potential contribution to kidney injury in vivo. Malat1 was upregulated in kidney biopsies and plasma of patients with AKI, in murine hypoxic kidney tissue as well as in cultured and ex vivo sorted hypoxic endothelial cells and tubular epithelial cells. Malat1 was transcriptionally activated by hypoxia-inducible factor 1-α. In vitro, Malat1 inhibition reduced proliferation and the number of endothelial cells in the S-phase of the cell cycle. In vivo, Malat1 knockout and wildtype mice showed similar degrees of outer medullary tubular epithelial injury, proliferation, capillary rarefaction, inflammation and fibrosis, survival and kidney function. Small-RNA sequencing and whole genome expression analysis revealed only minor changes between ischemic Malat1 knockout and wildtype mice. Contrary to previous studies, which suggested a prominent role of Malat1 in the induction of disease, we did not confirm an in vivo role of Malat1 concerning renal I/R-injury.
Collapse
Affiliation(s)
- Malte Kölling
- Department of Nephrology, University Hospital, Zürich, Switzerland.,Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany
| | - Celina Genschel
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany
| | | | - Anika Hübner
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany
| | - Song Rong
- Department of Nephrology, Hannover Medical School, Hannover, Germany
| | - Roland Schmitt
- Department of Nephrology, Hannover Medical School, Hannover, Germany
| | | | - George Haddad
- Department of Nephrology, University Hospital, Zürich, Switzerland
| | - Andreas Kistler
- Department of Internal Medicine, Cantonal Hospital Frauenfeld, Frauenfeld, Switzerland
| | - Harald Seeger
- Department of Nephrology, University Hospital, Zürich, Switzerland
| | - Jan T Kielstein
- Department of Nephrology, Städtisches Klinikum Braunschweig GmbH, Braunschweig, Germany
| | - Danilo Fliser
- Saarland University Medical Centre, Homburg/Saar, Germany
| | - Hermann Haller
- Department of Nephrology, Hannover Medical School, Hannover, Germany
| | - Rudolf Wüthrich
- Department of Nephrology, University Hospital, Zürich, Switzerland
| | - Martin Zörnig
- Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany
| | - Thomas Thum
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany.,National Heart and Lung Institute, Imperial College London, London, UK.,Excellence Cluster REBIRTH, Hannover Medical School, Hannover, Germany
| | - Johan Lorenzen
- Department of Nephrology, University Hospital, Zürich, Switzerland.
| |
Collapse
|
5
|
Wilke A, Bollmann U, Cazzaniga S, Hübner A, John S, Karadzinska-Bislimovska J, Mijakoski D, Šimić D, Simon D, Sonsmann F, Stoleski S, Weinert P, Wulfhorst B. The implementation of knowledge dissemination in the prevention of occupational skin diseases. J Eur Acad Dermatol Venereol 2017; 32:449-458. [DOI: 10.1111/jdv.14653] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2017] [Accepted: 09/25/2017] [Indexed: 11/30/2022]
Affiliation(s)
- A. Wilke
- Department of Dermatology, Environmental Medicine and Health Theory; University of Osnabrück; Osnabrück Germany
- Institute for Interdisciplinary Dermatological Prevention and Rehabilitation (iDerm); Osnabrück Germany
| | - U. Bollmann
- Institute for Work and Health (IAG) of the German Social Accident Insurance (DGUV); Dresden Germany
| | - S. Cazzaniga
- Centro Studi GISED; Bergamo Italy
- Department of Dermatology; Bern University Hospital; Inselspital; Bern Switzerland
| | - A. Hübner
- Institute for Interdisciplinary Dermatological Prevention and Rehabilitation (iDerm); Osnabrück Germany
| | - S.M. John
- Department of Dermatology, Environmental Medicine and Health Theory; University of Osnabrück; Osnabrück Germany
- Institute for Interdisciplinary Dermatological Prevention and Rehabilitation (iDerm); Osnabrück Germany
| | | | - D. Mijakoski
- Institute of Occupational Health of RM; Skopje FYR Macedonia
| | - D. Šimić
- Department of Dermatology and Venereology; University Clinical Hospital Mostar; Mostar Bosnia and Herzegovina
| | - D. Simon
- Department of Dermatology; Bern University Hospital; Inselspital; Bern Switzerland
| | - F. Sonsmann
- Department of Dermatology, Environmental Medicine and Health Theory; University of Osnabrück; Osnabrück Germany
- Institute for Interdisciplinary Dermatological Prevention and Rehabilitation (iDerm); Osnabrück Germany
| | - S. Stoleski
- Institute of Occupational Health of RM; Skopje FYR Macedonia
| | - P. Weinert
- Institute for Interdisciplinary Dermatological Prevention and Rehabilitation (iDerm); Osnabrück Germany
| | - B. Wulfhorst
- Faculty of Human Sciences; Department of Educational Sciences; MSH Medical School Hamburg; University of Applied Sciences and Medical University; Hamburg Germany
| |
Collapse
|
6
|
Schauerte C, Hübner A, Rong S, Wang S, Shushakova N, Mengel M, Dettling A, Bang C, Scherf K, Koelling M, Melk A, Haller H, Thum T, Lorenzen JM. Antagonism of profibrotic microRNA-21 improves outcome of murine chronic renal allograft dysfunction. Kidney Int 2017; 92:646-656. [PMID: 28396121 DOI: 10.1016/j.kint.2017.02.012] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2016] [Revised: 02/02/2017] [Accepted: 02/09/2017] [Indexed: 12/21/2022]
Abstract
Chronic renal allograft dysfunction (CAD) is a major limiting factor of long-term graft survival. It is characterized by interstitial fibrosis and tubular atrophy. The underlying pathomechanisms are incompletely understood. MicroRNAs are powerful regulators of gene expression and may have an impact on various diseases by direct mRNA decay or translational inhibition. A murine model of allogenic kidney transplantation was used resulting in CAD at 6 weeks after kidney transplantation. We identified fibrosis-associated miR-21a-5p by whole miRNAome expression analysis to be among the most highly upregulated miRNAs. In vitro in renal fibroblasts, miR-21a-5p was transcriptionally activated by interleukin 6-induced signal transducer and activator of transcription 3. Co-culture of LPS-activated macrophages with renal fibroblasts increased expression levels of miR-21a-5p and markers of fibrosis and inflammation. In addition, mature miR-21a-5p was secreted by macrophages in small vesicles, which were internalized by renal fibroblasts, thereby promoting profibrotic and proinflammatory effects. Notch2 receptor was identified as a potential target of miR-21a-5p and validated by luciferase gene reporter assays. Therapeutic silencing of miR-21a-5p in mice after allogenic kidney transplantation resulted in an amelioration of CAD, as indicated by a reduction in fibrosis development, inflammatory cell influx, tissue injury and BANFF lesion scoring. In a life-supporting model, miR-21a-5p antagonism had beneficial effects on kidney function. miR-21a-5p silencing may therefore be a viable therapeutic option in the treatment of patients following kidney transplantation to halt the development of CAD.
Collapse
Affiliation(s)
- Celina Schauerte
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Germany
| | - Anika Hübner
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Germany
| | - Song Rong
- Department of Nephrology, Hannover Medical School, Germany
| | - Shijun Wang
- Pediatric Research Center (PFZ), Hannover Medical School, Germany
| | | | - Michael Mengel
- Department of Laboratory Medicine & Pathology, University of Alberta, Canada
| | - Angela Dettling
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Germany
| | - Claudia Bang
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Germany
| | - Kristian Scherf
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Germany
| | - Malte Koelling
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Germany
| | - Anette Melk
- Pediatric Research Center (PFZ), Hannover Medical School, Germany
| | - Hermann Haller
- Department of Nephrology, Hannover Medical School, Germany
| | - Thomas Thum
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Germany; National Heart and Lung Institute, Imperial College London, UK.
| | - Johan M Lorenzen
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Germany; Department of Nephrology, Hannover Medical School, Germany; University Hospital Zürich, Switzerland.
| |
Collapse
|
7
|
Khuyagbaatar J, Yakushev A, Düllmann C, Ackermann D, Andersson LL, Block M, Brand H, Even J, Forsberg U, Hartmann W, Herzberg RD, Heßberger F, Hoffmann J, Hübner A, Jäger E, Jeppsson J, Kindler B, Kratz J, Krier J, Kurz N, Lommel B, Maiti M, Minami S, Rudolph D, Runke J, Sarmiento L, Schädel M, Schausten B, Steiner J, Heidenreich TTD, Uusitalo J, Wiehl N, Yakusheva V. Fission in the landscape of heaviest elements: Some recent examples. EPJ Web Conf 2016. [DOI: 10.1051/epjconf/201613103003] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
8
|
Schauerte C, Hübner A, Rong S, Mengel M, Melk A, Haller H, Thum T, Lorenzen J. SO005TRANSLATION OF ANTI FIBROTIC MICRORNA STRATEGIES INTO A MOUSE MODEL OF CHRONIC ALLOGRAFT DYSFUNCTION. Nephrol Dial Transplant 2016. [DOI: 10.1093/ndt/gfw117.05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
9
|
Khuyagbaatar J, Yakushev A, Düllmann CE, Ackermann D, Andersson LL, Block M, Brand H, Cox DM, Even J, Forsberg U, Golubev P, Hartmann W, Herzberg RD, Heßberger FP, Hoffmann J, Hübner A, Jäger E, Jeppsson J, Kindler B, Kratz JV, Krier J, Kurz N, Lommel B, Maiti M, Minami S, Mistry AK, Mrosek CM, Pysmenetska I, Rudolph D, Sarmiento LG, Schaffner H, Schädel M, Schausten B, Steiner J, De Heidenreich TT, Uusitalo J, Wegrzecki M, Wiehl N, Yakusheva V. New Short-Lived Isotope ^{221}U and the Mass Surface Near N=126. Phys Rev Lett 2015; 115:242502. [PMID: 26705628 DOI: 10.1103/physrevlett.115.242502] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/14/2015] [Indexed: 06/05/2023]
Abstract
Two short-lived isotopes ^{221}U and ^{222}U were produced as evaporation residues in the fusion reaction ^{50}Ti+^{176}Yb at the gas-filled recoil separator TASCA. An α decay with an energy of E_{α}=9.31(5) MeV and half-life T_{1/2}=4.7(7) μs was attributed to ^{222}U. The new isotope ^{221}U was identified in α-decay chains starting with E_{α}=9.71(5) MeV and T_{1/2}=0.66(14) μs leading to known daughters. Synthesis and detection of these unstable heavy nuclei and their descendants were achieved thanks to a fast data readout system. The evolution of the N=126 shell closure and its influence on the stability of uranium isotopes are discussed within the framework of α-decay reduced width.
Collapse
Affiliation(s)
- J Khuyagbaatar
- Helmholtz Institute Mainz, 55099 Mainz, Germany
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - A Yakushev
- Helmholtz Institute Mainz, 55099 Mainz, Germany
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - Ch E Düllmann
- Helmholtz Institute Mainz, 55099 Mainz, Germany
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
- Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - D Ackermann
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | | | - M Block
- Helmholtz Institute Mainz, 55099 Mainz, Germany
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
- Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - H Brand
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - D M Cox
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - J Even
- Helmholtz Institute Mainz, 55099 Mainz, Germany
| | | | | | - W Hartmann
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - R-D Herzberg
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - F P Heßberger
- Helmholtz Institute Mainz, 55099 Mainz, Germany
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - J Hoffmann
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - A Hübner
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - E Jäger
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | | | - B Kindler
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - J V Kratz
- Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - J Krier
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - N Kurz
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - B Lommel
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - M Maiti
- Saha Institute of Nuclear Physics, Kolkata 700064, India
| | - S Minami
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - A K Mistry
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - Ch M Mrosek
- Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - I Pysmenetska
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | | | | | - H Schaffner
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - M Schädel
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - B Schausten
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - J Steiner
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | | | - J Uusitalo
- University of Jyväskylä, 40351 Jyväskylä, Finland
| | - M Wegrzecki
- The Institute of Electron Technology, 02-668 Warsaw, Poland
| | - N Wiehl
- Helmholtz Institute Mainz, 55099 Mainz, Germany
- Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - V Yakusheva
- Helmholtz Institute Mainz, 55099 Mainz, Germany
| |
Collapse
|
10
|
Lorenzen JM, Schauerte C, Kölling M, Hübner A, Knapp M, Haller H, Thum T. Long Noncoding RNAs in Urine Are Detectable and May Enable Early Detection of Acute T Cell-Mediated Rejection of Renal Allografts. Clin Chem 2015; 61:1505-14. [PMID: 26506996 DOI: 10.1373/clinchem.2015.243600] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2015] [Accepted: 09/15/2015] [Indexed: 12/23/2022]
Abstract
BACKGROUND Long noncoding RNAs (lncRNAs) are novel intracellular noncoding ribonucleotides regulating the genome and proteome. They are detectable in the blood of patients with acute kidney injury. We tested whether lncRNAs are present in urine and may serve as new predictors of outcome in renal transplant patients with acute rejection. METHODS A global lncRNA expression analysis was performed with RNA from urine of patients with acute T cell-mediated renal allograft rejection and control transplant patients. Deregulated lncRNAs were confirmed in kidney biopsies and urine in a validation cohort of 62 patients with acute rejection, 10 of them after successful antirejection therapy, and 31 control transplant patients. RESULTS A global screen revealed several lncRNAs to be deregulated in urine of patients with acute rejection. Three intergenic lncRNAs, LNC-MYH13-3:1, RP11-395P13.3-001, and RP11-354P17.15-001, were most strongly altered. These were validated in the whole cohort of patients. RP11-395P13.3-001 and RP11-354P17.15-001 were upregulated in patients with acute rejection compared with controls. Only levels of RP11-354P17.15-001 normalized in patients with acute rejection after successful antirejection therapy. RP11-354P17.15-001 was associated with higher decline in glomerular filtration rate 1 year after transplantation. In vitro, in tubular epithelial cells, all lncRNAs were enriched by interleukin-6 treatment, but only RP11-395P13.3-001 and RP11-354P17.15-001 increased in cell culture supernatant, indicating that these lncRNAs might be secreted under inflammatory conditions. CONCLUSIONS lncRNAs are strongly altered in urine of patients with acute rejection. Urinary RP11-354P17.15-001 may serve as a novel biomarker of acute kidney rejection, identifying patients with acute rejection and predicting loss of kidney function.
Collapse
Affiliation(s)
- Johan M Lorenzen
- Institute of Molecular and Translational Therapeutic Strategies and Department of Medicine, Division of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
| | - Celina Schauerte
- Institute of Molecular and Translational Therapeutic Strategies and
| | - Malte Kölling
- Institute of Molecular and Translational Therapeutic Strategies and
| | - Anika Hübner
- Institute of Molecular and Translational Therapeutic Strategies and
| | - Monika Knapp
- Institute of Molecular and Translational Therapeutic Strategies and
| | - Hermann Haller
- Department of Medicine, Division of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
| | - Thomas Thum
- Institute of Molecular and Translational Therapeutic Strategies and
| |
Collapse
|
11
|
Al-Batran SE, Hozaeel W, Tauchert FK, Hofheinz RD, Hinke A, Windemuth-Kieselbach C, Hübner A, Burmester M, Koenigsmann M, Wiegand J, Zur Hausen G, Linsse B, Kuhl R, Pauligk C. The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax). Ann Oncol 2015; 26:1244-1248. [PMID: 25755108 DOI: 10.1093/annonc/mdv129] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2014] [Accepted: 02/18/2015] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Docetaxel is a widely used cytotoxic agent. This study evaluates the impact of docetaxel toxicities on patient's health-related quality of life (QoL). PATIENTS AND METHODS We conducted a multicenter, prospective, non-interventional trial, in which the QoL was assessed using the EORTC QLQ-C30 questionnaires at baseline and every 4 weeks up to 40 weeks in patients receiving a docetaxel-based chemotherapy for metastatic disease. Treatment-related adverse events were correlated with the corresponding QoL scores. Uni- and multivariate analyses were applied. RESULTS From January 2008 to June 2011, a total of 2659 patients were included. The majority of patients (48.1%) had prostate cancer, followed by breast (17.1%) and non-small-cell-lung cancer (15.8%). Patients received a median of 5 docetaxel cycles with the median dose of 75 mg/m(2). The presence of grade 3/4 diarrhea showed the strongest effect on global health status/QoL average scores (50.91 versus 33.06), followed by vomiting (50.91 versus 35.17), dyspnea (50.94 versus 35.81), mucositis/stomatitis (50.88 versus 36.41), nausea (50.91 versus 36.68), infection (50.90 versus 37.14), fatigue (50.90 versus 43.82) and anemia (50.91 versus 41.03), P < 0.05 for all comparisons. Grade 3/4 leukopenia/neutropenia, alopecia, constipation, neurotoxicity and nail disorders had no significant impact on the global health status/QoL or other items. CONCLUSION In this large non-interventional trial, docetaxel-associated grade 3 or 4 toxicities were shown to have a strong detrimental effect on patient's QoL. Notably, diarrhea and vomiting had the strongest negative impact on QoL measures. This has to be kept in mind while making therapeutic decisions and providing optimized supportive treatment measures. CLINICAL TRIALS NUMBER This study was registered at Deutsches Krebsstudienregister (DKSR, primary registry in the WHO Registry Network) with the ID 527.
Collapse
Affiliation(s)
- S-E Al-Batran
- Institute of Clinical Cancer Research, Krankenhaus Nordwest, University Cancer Center, Frankfurt.
| | - W Hozaeel
- Institute of Clinical Cancer Research, Krankenhaus Nordwest, University Cancer Center, Frankfurt
| | - F K Tauchert
- Clinic for Oncology and Hematology, Krankenhaus Nordwest, Frankfurt
| | - R-D Hofheinz
- Interdisciplinary Tumour Centre, University Hospital Mannheim, Mannheim
| | - A Hinke
- WiSP Research Institute, Langenfeld
| | | | - A Hübner
- Oncology and Urology, Wissenschaftskontor Nord GmbH & Co KG, Rostock
| | - M Burmester
- Clinic for Urology, Vinzenzkrankenhaus Hannover, Hannover
| | - M Koenigsmann
- Oncology and Hematology, Onkologisches Ambulanzzentrum, Hannover
| | - J Wiegand
- Oncology and Hematology, Onkologische Praxis, Moers
| | - G Zur Hausen
- Institute of Clinical Cancer Research, Krankenhaus Nordwest, University Cancer Center, Frankfurt
| | | | - R Kuhl
- Medical Oncology, Sanofi-Aventis Deutschland GmbH, Berlin, Germany
| | - C Pauligk
- Institute of Clinical Cancer Research, Krankenhaus Nordwest, University Cancer Center, Frankfurt
| |
Collapse
|
12
|
Lorenzen JM, Schauerte C, Hübner A, Kölling M, Martino F, Scherf K, Batkai S, Zimmer K, Foinquinos A, Kaucsar T, Fiedler J, Kumarswamy R, Bang C, Hartmann D, Gupta SK, Kielstein J, Jungmann A, Katus HA, Weidemann F, Müller OJ, Haller H, Thum T. Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis. Eur Heart J 2015; 36:2184-96. [PMID: 25898844 PMCID: PMC4543785 DOI: 10.1093/eurheartj/ehv109] [Citation(s) in RCA: 101] [Impact Index Per Article: 11.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/30/2014] [Accepted: 03/17/2015] [Indexed: 01/06/2023] Open
Abstract
Aims Osteopontin (OPN) is a multifunctional cytokine critically involved in cardiac fibrosis. However, the underlying mechanisms are unresolved. Non-coding RNAs are powerful regulators of gene expression and thus might mediate this process. Methods and results OPN and miR-21 were significantly increased in cardiac biopsies of patients with myocardial fibrosis. Ang II infusion via osmotic minipumps led to specific miRNA regulations with miR-21 being strongly induced in wild-type (WT) but not OPN knockout (KO) mice. This was associated with enhanced cardiac collagen content, myofibroblast activation, ERK-MAP kinase as well as AKT signalling pathway activation and a reduced expression of Phosphatase and Tensin Homologue (PTEN) as well as SMAD7 in WT but not OPN KO mice. In contrast, cardiotropic AAV9-mediated overexpression of OPN in vivo further enhanced cardiac fibrosis. In vitro, Ang II induced expression of miR-21 in WT cardiac fibroblasts, while miR-21 levels were unchanged in OPN KO fibroblasts. As pri-miR-21 was also increased by Ang II, we studied potential involved upstream regulators; Electrophoretic Mobility Shift and Chromatin Immunoprecipitation analyses confirmed activation of the miR-21 upstream-transcription factor AP-1 by Ang II. Recombinant OPN directly activated miR-21, enhanced fibrosis, and activated the phosphoinositide 3-kinase pathway. Locked nucleic acid-mediated miR-21 silencing ameliorated cardiac fibrosis development in vivo. Conclusion In cardiac fibrosis related to Ang II, miR-21 is transcriptionally activated and targets PTEN/SMAD7 resulting in increased fibroblast survival. OPN KO animals are protected from miR-21 increase and fibrosis development due to impaired AP-1 activation and fibroblast activation. Osteopontin (OPN) is a pleiotropic cytokine, which has been shown to be a pivotal factor in myofibroblast activation in cardiac fibrosis, thereby acting as a strong driver of heart failure development in humans. MicroRNAs (miRNAs) are under intense investigation as powerful regulators of various diseases. First phase I and II clinical trials using miRNA inhibitors have been initiated. We here show, that OPN is essential in the activation of AP-1 and subsequent transcription of miR-21 in cardiac fibrosis related to Ang II. OPN null mice are protected from miR-21 increase and fibrosis development due to impaired AP-1 activation and fibroblast activation. In the future, these findings may result in miRNA therapeutic approaches to treat patients with cardiac remodelling, in which levels of OPN and miR-21 are increased.
Collapse
Affiliation(s)
- Johan M Lorenzen
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany Department of Internal Medicine, Division of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
| | - Celina Schauerte
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
| | - Anika Hübner
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
| | - Malte Kölling
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
| | - Filippo Martino
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
| | - Kristian Scherf
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
| | - Sandor Batkai
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
| | - Karina Zimmer
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
| | - Ariana Foinquinos
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
| | - Tamas Kaucsar
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
| | - Jan Fiedler
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
| | - Regalla Kumarswamy
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
| | - Claudia Bang
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
| | - Dorothee Hartmann
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
| | - Shashi K Gupta
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
| | - Jan Kielstein
- Department of Internal Medicine, Division of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
| | - Andreas Jungmann
- University Hospital Heidelberg, Internal Medicine III, Heidelberg, Germany
| | - Hugo A Katus
- University Hospital Heidelberg, Internal Medicine III, Heidelberg, Germany DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, Germany
| | - Frank Weidemann
- Department of Cardiology and Angiology, Würzburg University, Würzburg, Germany
| | - Oliver J Müller
- University Hospital Heidelberg, Internal Medicine III, Heidelberg, Germany DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, Germany
| | - Hermann Haller
- Department of Internal Medicine, Division of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
| | - Thomas Thum
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany National Heart and Lung Institute, Imperial College London, London, UK
| |
Collapse
|
13
|
Lorenzen JM, Schauerte C, Kielstein JT, Hübner A, Martino F, Fiedler J, Gupta SK, Faulhaber-Walter R, Kumarswamy R, Hafer C, Haller H, Fliser D, Thum T. Circulating long noncoding RNATapSaki is a predictor of mortality in critically ill patients with acute kidney injury. Clin Chem 2014; 61:191-201. [PMID: 25294924 DOI: 10.1373/clinchem.2014.230359] [Citation(s) in RCA: 92] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
BACKGROUND Long noncoding RNAs (lncRNAs) are novel intracellular noncoding ribonucleotides regulating gene expression. Intriguingly, these RNA transcripts are detectable and stable in the blood of patients with cancer and cardiovascular disease. We tested whether circulating lncRNAs in plasma of critically ill patients with acute kidney injury (AKI) at inception of renal replacement therapy were deregulated and might predict survival. METHODS We performed a global lncRNA expression analysis using RNA isolated from plasma of patients with AKI, healthy controls, and ischemic disease controls. This global screen revealed several deregulated lncRNAs in plasma samples of patients with AKI. lncRNA-array-based alterations were confirmed in kidney biopsies of patients as well as in plasma of 109 patients with AKI, 30 age-matched healthy controls, and 30 disease controls by quantitative real-time PCR. RESULTS Circulating concentrations of the novel intronic antisense lncRNA TrAnscript Predicting Survival in AKI (TapSAKI) (P < 0.0001) were detectable in kidney biopsies and upregulated in plasma of patients with AKI. Cox regression and Kaplan-Meier curve analysis revealed TapSAKI as an independent predictor of 28-day survival (P < 0.01). TapSAKI was enriched in tubular epithelial cells subjected to ATP depletion (P = 0.03). CONCLUSIONS The alteration of circulating concentrations of lncRNAs in patients with AKI supports TapSAKI as a predictor of mortality in this patient cohort.
Collapse
Affiliation(s)
- Johan M Lorenzen
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS) and Department of Medicine/Division of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany;
| | - Celina Schauerte
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS) and
| | - Jan T Kielstein
- Department of Medicine/Division of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
| | - Anika Hübner
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS) and
| | - Filippo Martino
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS) and
| | - Jan Fiedler
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS) and
| | - Shashi K Gupta
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS) and
| | - Robert Faulhaber-Walter
- Department of Medicine/Division of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
| | - Regalla Kumarswamy
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS) and
| | - Carsten Hafer
- Department of Medicine/Division of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
| | - Hermann Haller
- Department of Medicine/Division of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
| | - Danilo Fliser
- Saarland University Medical Centre, Homburg/Saar, Germany
| | - Thomas Thum
- Institute of Molecular and Translational Therapeutic Strategies (IMTTS) and National Heart and Lung Institute, Imperial College London, London, UK.
| |
Collapse
|
14
|
Equit M, Hill J, Hübner A, von Gontard A. Health-related quality of life and treatment effects on children with functional incontinence, and their parents. J Pediatr Urol 2014; 10:922-8. [PMID: 24726201 DOI: 10.1016/j.jpurol.2014.03.002] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/07/2013] [Accepted: 03/01/2014] [Indexed: 12/11/2022]
Abstract
OBJECTIVE To analyze treatment outcomes and the association between treatment effects and health-related quality of life (HRQoL) for incontinent children, and their parents. SUBJECTS AND METHODS Health-related quality of life in 70 consecutively treated children, and their parents, was assessed with the Pediatric Incontinence Questionnaire and the WHO-Quality-Of-Life-BREF questionnaire. This was assessed before and after three months of standardized treatment. RESULTS In 44.3% of children, symptoms decreased by 50-89%. After three months of treatment, the HRQoL of children improved significantly. Children with bladder and bowel dysfunction had a significantly lower HRQoL than children with isolated nocturnal enuresis, daytime urinary incontinence or fecal incontinence. Parental HRQoL did not change significantly within three months of treatment. Parents showed a significantly lower mean in the 'psychological' domain of the WHO-QoL-BREF questionnaire compared to norms. CONCLUSION Children with different subtypes of incontinence can be treated effectively within three months of therapy. After three months, significant improvements of HRQoL were shown. Parents showed no general reduction in their quality of life (QoL). Specific aspects of parental QoL were impaired, but did not improve during the treatment of their children.
Collapse
Affiliation(s)
- M Equit
- Department of Child and Adolescent Psychiatry, Saarland University Hospital, 66421 Homburg, Saar, Germany.
| | - J Hill
- Department of Child and Adolescent Psychiatry, Saarland University Hospital, 66421 Homburg, Saar, Germany.
| | - A Hübner
- Department of Child and Adolescent Psychiatry, Saarland University Hospital, 66421 Homburg, Saar, Germany.
| | - A von Gontard
- Department of Child and Adolescent Psychiatry, Saarland University Hospital, 66421 Homburg, Saar, Germany.
| |
Collapse
|
15
|
Storjohann B, Pliszewski M, Diezel U, Bieberstein H, Petri H, Hübner A, Korn-Clicqué R, Beckmann MW. Tod am Anfang des Lebens – Eine Wanderaustellung. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
16
|
Lorenzen JM, Kaucsar T, Schauerte C, Schmitt R, Rong S, Hübner A, Scherf K, Fiedler J, Martino F, Kumarswamy R, Kölling M, Sörensen I, Hinz H, Heineke J, van Rooij E, Haller H, Thum T. MicroRNA-24 antagonism prevents renal ischemia reperfusion injury. J Am Soc Nephrol 2014; 25:2717-29. [PMID: 24854275 DOI: 10.1681/asn.2013121329] [Citation(s) in RCA: 106] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
Ischemia-reperfusion (I/R) injury of the kidney is a major cause of AKI. MicroRNAs (miRs) are powerful regulators of various diseases. We investigated the role of apoptosis-associated miR-24 in renal I/R injury. miR-24 was upregulated in the kidney after I/R injury of mice and in patients after kidney transplantation. Cell-sorting experiments revealed a specific miR-24 enrichment in renal endothelial and tubular epithelial cells after I/R induction. In vitro, anoxia/hypoxia induced an enrichment of miR-24 in endothelial and tubular epithelial cells. Transient overexpression of miR-24 alone induced apoptosis and altered functional parameters in these cells, whereas silencing of miR-24 ameliorated apoptotic responses and rescued functional parameters in hypoxic conditions. miR-24 effects were mediated through regulation of H2A histone family, member X, and heme oxygenase 1, which were experimentally validated as direct miR-24 targets through luciferase reporter assays. In vitro, adenoviral overexpression of miR-24 targets lacking miR-24 binding sites along with miR-24 precursors rescued various functional parameters in endothelial and tubular epithelial cells. In vivo, silencing of miR-24 in mice before I/R injury resulted in a significant improvement in survival and kidney function, a reduction of apoptosis, improved histologic tubular epithelial injury, and less infiltration of inflammatory cells. miR-24 also regulated heme oxygenase 1 and H2A histone family, member X, in vivo. Overall, these results indicate miR-24 promotes renal ischemic injury by stimulating apoptosis in endothelial and tubular epithelial cell. Therefore, miR-24 inhibition may be a promising future therapeutic option in the treatment of patients with ischemic AKI.
Collapse
Affiliation(s)
- Johan M Lorenzen
- Institute of Molecular and Translational Therapeutic Strategies, Department of Nephrology, and
| | - Tamas Kaucsar
- Institute of Molecular and Translational Therapeutic Strategies, Institute of Pathophysiology, Semmelweis University, Budapest, Hungary
| | | | | | | | - Anika Hübner
- Institute of Molecular and Translational Therapeutic Strategies
| | - Kristian Scherf
- Institute of Molecular and Translational Therapeutic Strategies
| | - Jan Fiedler
- Institute of Molecular and Translational Therapeutic Strategies
| | - Filippo Martino
- Institute of Molecular and Translational Therapeutic Strategies
| | | | - Malte Kölling
- Institute of Molecular and Translational Therapeutic Strategies
| | | | - Hebke Hinz
- Department of Cardiology and Angiology, Hannover Medical School, Hannover Germany
| | - Joerg Heineke
- Department of Cardiology and Angiology, Hannover Medical School, Hannover Germany
| | - Eva van Rooij
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, and University Medical Center Utrecht, Utrecht, The Netherlands; and
| | | | - Thomas Thum
- Institute of Molecular and Translational Therapeutic Strategies, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
| |
Collapse
|
17
|
Khuyagbaatar J, Yakushev A, Düllmann CE, Ackermann D, Andersson LL, Asai M, Block M, Boll RA, Brand H, Cox DM, Dasgupta M, Derkx X, Di Nitto A, Eberhardt K, Even J, Evers M, Fahlander C, Forsberg U, Gates JM, Gharibyan N, Golubev P, Gregorich KE, Hamilton JH, Hartmann W, Herzberg RD, Heßberger FP, Hinde DJ, Hoffmann J, Hollinger R, Hübner A, Jäger E, Kindler B, Kratz JV, Krier J, Kurz N, Laatiaoui M, Lahiri S, Lang R, Lommel B, Maiti M, Miernik K, Minami S, Mistry A, Mokry C, Nitsche H, Omtvedt JP, Pang GK, Papadakis P, Renisch D, Roberto J, Rudolph D, Runke J, Rykaczewski KP, Sarmiento LG, Schädel M, Schausten B, Semchenkov A, Shaughnessy DA, Steinegger P, Steiner J, Tereshatov EE, Thörle-Pospiech P, Tinschert K, Torres De Heidenreich T, Trautmann N, Türler A, Uusitalo J, Ward DE, Wegrzecki M, Wiehl N, Van Cleve SM, Yakusheva V. 48Ca+249Bk fusion reaction leading to element Z = 117: long-lived α-decaying 270Db and discovery of 266Lr. Phys Rev Lett 2014; 112:172501. [PMID: 24836239 DOI: 10.1103/physrevlett.112.172501] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/22/2014] [Indexed: 06/03/2023]
Abstract
The superheavy element with atomic number Z=117 was produced as an evaporation residue in the (48)Ca+(249)Bk fusion reaction at the gas-filled recoil separator TASCA at GSI Darmstadt, Germany. The radioactive decay of evaporation residues and their α-decay products was studied using a detection setup that allowed measuring decays of single atomic nuclei with half-lives between sub-μs and a few days. Two decay chains comprising seven α decays and a spontaneous fission each were identified and are assigned to the isotope (294)117 and its decay products. A hitherto unknown α-decay branch in (270)Db (Z = 105) was observed, which populated the new isotope (266)Lr (Z = 103). The identification of the long-lived (T(1/2) = 1.0(-0.4)(+1.9) h) α-emitter (270)Db marks an important step towards the observation of even more long-lived nuclei of superheavy elements located on an "island of stability."
Collapse
Affiliation(s)
- J Khuyagbaatar
- Helmholtz Institute Mainz, 55099 Mainz, Germany and GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - A Yakushev
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - Ch E Düllmann
- Helmholtz Institute Mainz, 55099 Mainz, Germany and GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany and Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - D Ackermann
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | | | - M Asai
- Advanced Science Research Center, Japan Atomic Energy Agency, Tokai, Ibaraki 319-1195, Japan
| | - M Block
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - R A Boll
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - H Brand
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - D M Cox
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - M Dasgupta
- The Australian National University, Canberra, Australian Capital Territory 0200, Australia
| | - X Derkx
- Helmholtz Institute Mainz, 55099 Mainz, Germany and Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - A Di Nitto
- Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - K Eberhardt
- Helmholtz Institute Mainz, 55099 Mainz, Germany and Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - J Even
- Helmholtz Institute Mainz, 55099 Mainz, Germany
| | - M Evers
- The Australian National University, Canberra, Australian Capital Territory 0200, Australia
| | | | | | - J M Gates
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - N Gharibyan
- Lawrence Livermore National Laboratory, Livermore, California 94551, USA
| | | | - K E Gregorich
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - J H Hamilton
- Vanderbilt University, Nashville, Tennessee 37235, USA
| | - W Hartmann
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - R-D Herzberg
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - F P Heßberger
- Helmholtz Institute Mainz, 55099 Mainz, Germany and GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - D J Hinde
- The Australian National University, Canberra, Australian Capital Territory 0200, Australia
| | - J Hoffmann
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - R Hollinger
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - A Hübner
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - E Jäger
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - B Kindler
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - J V Kratz
- Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - J Krier
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - N Kurz
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - M Laatiaoui
- Helmholtz Institute Mainz, 55099 Mainz, Germany
| | - S Lahiri
- Saha Institute of Nuclear Physics, Kolkata 700064, India
| | - R Lang
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - B Lommel
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - M Maiti
- Saha Institute of Nuclear Physics, Kolkata 700064, India
| | - K Miernik
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - S Minami
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - A Mistry
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - C Mokry
- Helmholtz Institute Mainz, 55099 Mainz, Germany and Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - H Nitsche
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | | | - G K Pang
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - P Papadakis
- University of Liverpool, Liverpool L69 7ZE, United Kingdom and University of Jyväskylä, 40351 Jyväskylä, Finland
| | - D Renisch
- Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - J Roberto
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | | | - J Runke
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - K P Rykaczewski
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | | | - M Schädel
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany and Advanced Science Research Center, Japan Atomic Energy Agency, Tokai, Ibaraki 319-1195, Japan
| | - B Schausten
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | | | - D A Shaughnessy
- Lawrence Livermore National Laboratory, Livermore, California 94551, USA
| | - P Steinegger
- Paul Scherrer Institute, 5232 Villigen, Switzerland and University of Bern, 3012 Bern, Switzerland
| | - J Steiner
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - E E Tereshatov
- Lawrence Livermore National Laboratory, Livermore, California 94551, USA
| | - P Thörle-Pospiech
- Helmholtz Institute Mainz, 55099 Mainz, Germany and Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - K Tinschert
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | | | - N Trautmann
- Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - A Türler
- Paul Scherrer Institute, 5232 Villigen, Switzerland and University of Bern, 3012 Bern, Switzerland
| | - J Uusitalo
- University of Jyväskylä, 40351 Jyväskylä, Finland
| | - D E Ward
- Lund University, 22100 Lund, Sweden
| | - M Wegrzecki
- Institute of Electron Technology, 02-668 Warsaw, Poland
| | - N Wiehl
- Helmholtz Institute Mainz, 55099 Mainz, Germany and Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - S M Van Cleve
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - V Yakusheva
- Helmholtz Institute Mainz, 55099 Mainz, Germany
| |
Collapse
|
18
|
Näke A, Pyper A, Laass M, Hübner A. Eine seltene Diabetesform: das Wolcott-Rallison-Syndrom (Fallbeschreibung). DIABETOL STOFFWECHS 2012. [DOI: 10.1055/s-0032-1314504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
19
|
Hübner A, Horsfield B, Kapp I. Shale Gas in Europe: pragmatic perspectives and actions. EPJ Web of Conferences 2012. [DOI: 10.1051/epjconf/20123303006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
20
|
Faenger B, Hübner A, Anders C. Leistungsfähigkeit der Rumpfmuskulatur von jungen und alten gesunden Personen. Pneumologie 2011. [DOI: 10.1055/s-0031-1274947] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
21
|
Düllmann CE, Schädel M, Yakushev A, Türler A, Eberhardt K, Kratz JV, Ackermann D, Andersson LL, Block M, Brüchle W, Dvorak J, Essel HG, Ellison PA, Even J, Gates JM, Gorshkov A, Graeger R, Gregorich KE, Hartmann W, Herzberg RD, Hessberger FP, Hild D, Hübner A, Jäger E, Khuyagbaatar J, Kindler B, Krier J, Kurz N, Lahiri S, Liebe D, Lommel B, Maiti M, Nitsche H, Omtvedt JP, Parr E, Rudolph D, Runke J, Schausten B, Schimpf E, Semchenkov A, Steiner J, Thörle-Pospiech P, Uusitalo J, Wegrzecki M, Wiehl N. Production and decay of element 114: high cross sections and the new nucleus 277Hs. Phys Rev Lett 2010; 104:252701. [PMID: 20867370 DOI: 10.1103/physrevlett.104.252701] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2009] [Indexed: 05/29/2023]
Abstract
The fusion-evaporation reaction 244Pu(48Ca,3-4n){288,289}114 was studied at the new gas-filled recoil separator TASCA. Thirteen correlated decay chains were observed and assigned to the production and decay of {288,289}114. At a compound nucleus excitation energy of E{*}=39.8-43.9 MeV, the 4n evaporation channel cross section was 9.8{-3.1}{+3.9} pb. At E^{*}=36.1-39.5 MeV, that of the 3n evaporation channel was 8.0{-4.5}{+7.4} pb. In one of the 3n evaporation channel decay chains, a previously unobserved α branch in 281Ds was observed (probability to be of random origin from background: 0.1%). This α decay populated the new nucleus 277Hs, which decayed by spontaneous fission after a lifetime of 4.5 ms.
Collapse
Affiliation(s)
- Ch E Düllmann
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Trump DL, Payne H, Miller K, De Bono JS, Stephenson J, Burris HA, Nathan FE, Taboada M, Morris T, Hübner A. Phase I study of the specific endothelin A receptor antagonist zibotentan (ZD4054) combined with docetaxel in patients with metastatic castration-resistant prostate cancer: Assessment of efficacy, pain, and safety. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.4664] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
23
|
Smitka M, Hahn G, Hübner A. Evaluation of rhabdomyolysis with muscle-MRI – case report of a 4 year old boy with a mutation in the LPIN1 Gen. KLIN NEUROPHYSIOL 2010. [DOI: 10.1055/s-0030-1250879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
24
|
Thiele S, Werner R, Ahrens W, Hübner A, Hinkel KG, Höppner W, Igl B, Hiort O. Selective deficiency of Gsalpha and the possible role of alternative gene products of GNAS in Albright hereditary osteodystrophy and pseudohypoparathyroidism type Ia. Exp Clin Endocrinol Diabetes 2009; 118:127-32. [PMID: 19658058 DOI: 10.1055/s-0029-1215589] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
OBJECTIVE Albright hereditary osteodystrophy (AHO) and Pseudohypoparathyroidism type Ia (PHPIa) are caused by an inherited deficiency of Gsalpha, encoded by the GNAS gene. Apart from an exclusive first exon, Gsalpha shares part of the transcribed regions with NESP55, Exon A/B and XLalphas, whose gene products utilize alternative promoter regions of this complex gene locus. However, it is not known, whether the deficiency of all gene products contributes to the AHO and PHPIa phenotype or if they are even causative for some specific symptoms. In these cases, mutations affecting selectively GNAS exon 1, coding only for Gsalpha, would lead to a different phenotype than mutations affecting the common exons 2-13. METHODS Clinical and molecular genetic analysis of a patient with features of AHO and review of exclusive exon 1 mutations of GNAS. RESULTS We detected a novel heterozygous 1 bp deletion of a guanine in codon 31 in exon 1 of the GNAS gene leading to a frame shift and premature termination of Gsalpha. The female patient demonstrated a fully expressed AHO and PHPIa phenotype and a decreased Gsalpha protein activity of 62% compared to the wild type. Mutations in exon 1 are almost exclusively disruptive and lead to an AHO phenotype that does not show obvious differences from those provoked by missense or nonsense mutations in exon 2-13. CONCLUSION Disruptive mutations in exon 1 indicate that exclusive deficiency of Gsalpha is sufficient for the expression of an AHO phenotype, which cannot be compensated by alternative products of GNAS.
Collapse
Affiliation(s)
- S Thiele
- 1Departments of Pediatrics, University of Lübeck, 23538Lübeck, Germany
| | | | | | | | | | | | | | | |
Collapse
|
25
|
Hübner A, Radehaus P. Einfluss von lasertechnisch erzeugten Oberflächenstrukturen auf Fibroblasten. CHEM-ING-TECH 2009. [DOI: 10.1002/cite.200950091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
26
|
|
27
|
|
28
|
|
29
|
Krafft A, Hübner A, Gadient S, Werth E, Zimmermann R, Bassetti C. Restless legs Syndrom in der Schwangerschaft: Eine prospektive, systematische Studie – Ein unterschätztes Problem in der Schwangerschaft. Z Geburtshilfe Neonatol 2009. [DOI: 10.1055/s-0029-1222719] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
30
|
Fischer D, Olive M, Kley R, Strach K, Hübner A, Udd B, Fardeau M, Goldfarb L, Studer A, Weber M. Identification of first Swiss desminopathy families using systematic muscle imaging in myofibrillar myopathies. Clin Neurophysiol 2008. [DOI: 10.1016/j.clinph.2007.09.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
31
|
Mikeska T, Bock C, El-Maarri O, Hübner A, Ehrentraut D, Schramm J, Felsberg J, Kahl P, Büttner R, Pietsch T, Waha A. Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis. J Mol Diagn 2007; 9:368-81. [PMID: 17591937 PMCID: PMC1899414 DOI: 10.2353/jmoldx.2007.060167] [Citation(s) in RCA: 173] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
Resistance to chemotherapy is a major complication during treatment of cancer patients. Hypermethylation of the MGMT gene alters DNA repair and is associated with longer survival of glioblastoma patients treated with alkylating agents. Therefore, MGMT promoter methylation plays an important role as a predictive biomarker for chemotherapy resistance. To adopt this established correlation into a molecular diagnosis procedure, we compared and optimized three experimental techniques [combined bisulfite restriction analysis, a primer extension- and denaturing high-performance liquid chromatography-based method named SIRPH (SNuPE ion pair-reverse phase high-performance liquid chromatography), and pyrosequencing] with regard to their accuracy of detecting MGMT promoter methylation. Initially, bisulfite sequencing was used to obtain a comprehensive methylation profile of the MGMT promoter region in 22 glioblastoma samples and in three normal brain controls. Next, we statistically identified CpG sites that best discriminate between methylated and unmethylated MGMT promoters. These results were then used to design optimal combined bisulfite restriction analysis, SIRPH, and pyrosequencing assays for accurate and cost-efficient assessment of MGMT promoter methylation. We compared all three techniques with regard to their reliability and reproducibility on well-characterized tumor samples. The optimized pyrosequencing assay performed best and provides a sensitive, robust, and easy-to-use method for quantitative assessment of MGMT methylation, for both snap-frozen and paraffin-embedded specimens.
Collapse
Affiliation(s)
- Thomas Mikeska
- Department of Neuropathology, University of Bonn Medical Center, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Waha A, Koch A, Hartmann W, Milde U, Felsberg J, Hübner A, Mikeska T, Goodyer CG, Sörensen N, Lindberg I, Wiestler OD, Pietsch T, Waha A. SGNE1/7B2 is epigenetically altered and transcriptionally downregulated in human medulloblastomas. Oncogene 2007; 26:5662-8. [PMID: 17334394 DOI: 10.1038/sj.onc.1210338] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
In a genome-wide screen using differential methylation hybridization (DMH), we have identified a CpG island within the 5' region and untranslated first exon of the secretory granule neuroendocrine protein 1 gene (SGNE1/7B2) that showed hypermethylation in medulloblastomas compared to fetal cerebellum. Bisulfite sequencing and combined bisulfite restriction assay were performed to confirm the methylation status of this CpG island in primary medulloblastomas and medulloblastoma cell lines. Hypermethylation was detected in 16/23 (70%) biopsies and 7/8 (87%) medulloblastoma cell lines, but not in non-neoplastic fetal (n=8) cerebellum. Expression of SGNE1 was investigated by semi-quantitative competitive reverse transcription-polymerase chain reaction and found to be significantly downregulated or absent in all, but one primary medulloblastomas and all cell lines compared to fetal cerebellum. After treatment of medulloblastoma cell lines with 5-aza-2'-deoxycytidine, transcription of SGNE1 was restored. No mutation was found in the coding region of SGNE1 by single-strand conformation polymorphism analysis. Reintroduction of SGNE1 into the medulloblastoma cell line D283Med led to a significant growth suppression and reduced colony formation. In summary, we have identified SGNE1 as a novel epigenetically silenced gene in medulloblastomas. Its frequent inactivation, as well as its inhibitory effect on tumor cell proliferation and focus formation strongly argues for a significant role in medulloblastoma development.
Collapse
Affiliation(s)
- A Waha
- Department of Neuropathology, University of Bonn, Germany.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
von der Hagen M, Kaindl A, Kress W, Mitzscherling P, Hübner A, Reible C, Hahn G, Stoltenburg-Didinger G. P.P.5 02 Muscle MRI in a family with congenital myopathy with cores and rods associated with a novel missense mutation in the ryanodine receptor 1 gene. Neuromuscul Disord 2006. [DOI: 10.1016/j.nmd.2006.05.147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
34
|
Flury M, Schweigel J, Näke A, Hübner A. Lipoprotein a – pathogenetischer Faktor in der Entstehung des Diabetes mellitus im Kindesalter? DIABETOL STOFFWECHS 2006. [DOI: 10.1055/s-2006-944026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
35
|
Strauß M, Koehler K, Krumbholz M, Hübner A, Zierz S, Deschauer M. Allgrove-Syndrom als seltene Differentialdiagnose einer juvenilen ALS. Akt Neurol 2006. [DOI: 10.1055/s-2006-953331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
36
|
Hübner S, Eam JE, Hübner A, Jans DA. Laminopathy-inducing lamin A mutants can induce redistribution of lamin binding proteins into nuclear aggregates. Exp Cell Res 2005; 312:171-83. [PMID: 16289535 DOI: 10.1016/j.yexcr.2005.10.011] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2005] [Revised: 10/09/2005] [Accepted: 10/13/2005] [Indexed: 10/25/2022]
Abstract
Lamins, members of the family of intermediate filaments, form a supportive nucleoskeletal structure underlying the nuclear envelope and can also form intranuclear structures. Mutations within the A-type lamin gene cause a variety of degenerative diseases which are collectively referred to as laminopathies. At the molecular level, laminopathies have been shown to be linked to a discontinuous localization pattern of A-type lamins, with some laminopathies containing nuclear lamin A aggregates. Since nuclear aggregate formation could lead to the mislocalization of proteins interacting with A-type lamins, we set out to examine the effects of FLAG-lamin A N195K and R386K protein aggregate formation on the subnuclear distribution of the retinoblastoma protein (pRb) and the sterol responsive element binding protein 1a (SREBP1a) after coexpression as GFP-fusion proteins in HeLa cells. We observed strong recruitment of both proteins into nuclear aggregates. Nuclear aggregate recruitment of the NPC component nucleoporin NUP153 was also observed and found to be dependent on the N-terminus. That these effects were specific was implied by the fact that a number of other coexpressed karyophilic GFP-fusion proteins, such as the nucleoporin NUP98 and kanadaptin, did not coaggregate with FLAG-lamin A N195K or R386K. Immunofluorescence analysis further indicated that the precursor form of lamin A, pre-lamin A, could be found in intranuclear aggregates. Our results imply that redistribution into lamin A-/pre-lamin A-containing aggregates of proteins such as pRb and SREBP1a could represent a key aspect underlying the molecular pathogenesis of certain laminopathies.
Collapse
Affiliation(s)
- S Hübner
- Department of Biochemistry and Molecular Biology, Nuclear Signalling Laboratory, PO Box 13D, Monash University, Clayton, Victoria 3800, Australia.
| | | | | | | |
Collapse
|
37
|
Hübner A, Yang X, Nolen DM, Popova TG, Cabello FC, Norgard MV. Expression of Borrelia burgdorferi OspC and DbpA is controlled by a RpoN-RpoS regulatory pathway. Proc Natl Acad Sci U S A 2001; 98:12724-9. [PMID: 11675503 PMCID: PMC60121 DOI: 10.1073/pnas.231442498] [Citation(s) in RCA: 278] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2001] [Indexed: 11/18/2022] Open
Abstract
RpoS and RpoN are two alternative sigma factors typically associated with general stress responses in bacteria. To date, there has been no experimental evidence that RpoS and RpoN can directly control the expression of one another. Herein, using a combined strategy of gene disruption and genetic complementation targeting rpoN and rpoS in Borrelia burgdorferi strain 297, we describe a regulatory network for B. burgdorferi. In this network, RpoN controls the expression of RpoS, which, in turn, governs the expression of two important membrane lipoproteins, outer surface protein C and decorin-binding protein A, and likely other proteins of B. burgdorferi. Our findings provide a foundation for elucidating further key regulatory networks that potentially impact many aspects of B. burgdorferi's parasitic strategy, host range, and virulence expression.
Collapse
Affiliation(s)
- A Hübner
- Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
| | | | | | | | | | | |
Collapse
|
38
|
|
39
|
Hübner A, Danganan CE, Xun L, Chakrabarty AM, Hendrickson W. Genes for 2,4,5-trichlorophenoxyacetic acid metabolism in Burkholderia cepacia AC1100: characterization of the tftC and tftD genes and locations of the tft operons on multiple replicons. Appl Environ Microbiol 1998; 64:2086-93. [PMID: 9603818 PMCID: PMC106282 DOI: 10.1128/aem.64.6.2086-2093.1998] [Citation(s) in RCA: 60] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
Burkholderia cepacia AC1100 uses the chlorinated aromatic compound 2, 4,5-trichlorophenoxyacetic acid (2,4,5-T) as a sole source of carbon and energy. The enzyme which converts the first intermediate in the pathway, 2,4,5-trichlorophenol, to 5-chlorohydroquinone has been purified and consists of two subunits of 58 and 22 kDa, encoded by the tftC and tftD genes (48). A degenerate primer was designed from the N terminus of the 58-kDa polypeptide and used to isolate a clone containing the tftC and tftD genes from a genomic library of AC1100. The derived amino acid sequences of tftC and tftD show significant homology to the two-component monooxygenases HadA of Burkholderia pickettii, HpaBC of Escherichia coli, and HpaAH of Klebsiella pneumonia. Expression of the tftC and tftD genes appeared to be induced when they were grown in the presence of 2,4,5-T, as shown by RNA slot blot and primer extension analyses. Three sets of cloned tft genes were used as probes to explore the genomic organization of the pathway. Pulsed-field gel electrophoresis analyses of whole chromosomes of B. cepacia AC1100 demonstrated that the genome is comprised of five replicons of 4.0, 2.7, 0.53, 0.34, and 0.15 Mbp, designated I to V, respectively. The tft genes are located on the smaller replicons: the tftAB cluster is on replicon IV, tftEFGH is on replicon III, and copies of the tftC and the tftCD operons are found on both replicons III and IV. When cells were grown in the absence of 2,4,5-T, the genes were lost at high frequency by chromosomal deletions and rearrangements to produce 2,4,5-T-negative mutants. In one mutant, the tftA and tftB genes translocated from one replicon to another, with the concomitant loss of tftEFGH and one copy of tftCD.
Collapse
Affiliation(s)
- A Hübner
- Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, USA
| | | | | | | | | |
Collapse
|
40
|
Hübner A, Hendrickson W. A fusion promoter created by a new insertion sequence, IS1490, activates transcription of 2,4,5-trichlorophenoxyacetic acid catabolic genes in Burkholderia cepacia AC1100. J Bacteriol 1997; 179:2717-23. [PMID: 9098071 PMCID: PMC179022 DOI: 10.1128/jb.179.8.2717-2723.1997] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
Transposition and transcriptional activation by insertion sequences in Burkholderia cepacia AC1100 were investigated. Two closely related new elements, IS1413 and IS1490, were identified and characterized. These elements are not highly related to other insertion sequences identified in AC1100 or other B. cepacia isolates. Based on their structures and the sequences of the inverted terminal repeats and the putative transposase protein, the insertion elements (IS elements) are similar to IST2 of Thiobacillus ferrooxidans and several related elements. All the IS elements that have been identified in this strain are found in multiple copies (10 to 40), and they have high-level promoter activity capable of stimulating transcription from a distance up to 500 bp from a target gene. Strain AC1100 was originally isolated after prolonged selection for the ability to utilize the herbicide 2,4,5-trichlorophenoxyacetic acid (2,4,5-T) as a sole carbon source. Three IS elements are located near the first gene of the 2,4,5-T catabolic pathway, tftA. IS1490 inserted 110 bp upstream of tftA and created a fusion promoter responsible for constitutive transcription of the gene. Our results confirm the hypothesis that IS elements play a central role in transcription of 2,4,5-T genes and likely have stimulated rapid evolution of the metabolic pathway.
Collapse
Affiliation(s)
- A Hübner
- Department of Microbiology and Immunology, University of Illinois, Chicago 60612, USA
| | | |
Collapse
|
41
|
Daubaras DL, Danganan CE, Hübner A, Ye RW, Hendrickson W, Chakrabarty AM. Biodegradation of 2,4,5-trichlorophenoxyacetic acid by Burkholderia cepacia strain AC1100: evolutionary insight. Gene 1996; 179:1-8. [PMID: 8955624 DOI: 10.1016/s0378-1119(96)00326-5] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Many microorganisms in nature have evolved new genes which encode catabolic enzymes specific for chlorinated aromatic substrates, allowing them to utilize these compounds as sole sources of carbon and energy. An understanding of the evolutionary mechanisms involved in the acquisition of such genes may facilitate the development of microorganisms with enhanced capabilities of degrading highly chlorinated recalcitrant compounds. A number of studies have been based on microorganisms isolated from the environment which utilize simple chlorinated substrates. In our laboratory, a selective technique was used to isolate microorganisms capable of degrading highly chlorinated compounds, such as 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), as sole sources of carbon and energy. This article summarizes the genetic and biochemical information obtained regarding the pathway of degradation, the mechanism of recruitment of new genes, and the organization of the degradative genes. In addition, we discuss the potential practical application of such microorganisms in the environment.
Collapse
Affiliation(s)
- D L Daubaras
- Department of Microbiology and Immunology (M/C 790), College of Medicine, University of Illinois at Chicago 60612, USA
| | | | | | | | | | | |
Collapse
|
42
|
Terres W, Lund GK, Hübner A, Ehlert A, Reuter H, Hamm CW. Endogenous tissue plasminogen activator and platelet reactivity as risk factors for reocclusion after recanalization of chronic total coronary occlusions. Am Heart J 1995; 130:711-6. [PMID: 7572577 DOI: 10.1016/0002-8703(95)90068-3] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
A prospective study was performed to investigate the role of the endogenous fibrinolytic system and platelet function for the occurrence of reocclusion after successful recanalization of chronic coronary occlusions. At control coronary angiography 8 +/- 2 weeks after recanalization, reocclusion was found in 10 (21%) of 47 patients. After correction for angiographic and clinical confounding factors, endogenous concentrations of tissue plasminogen activator (TPA) were lower in patients with reocclusion than in patients without. In contrast, plasma levels of plasminogen activator inhibitor-1 and alpha 2-antiplasmin were similar in the two groups. The mean platelet volume was significantly higher in patients with reocclusion than in patients without. In addition, agonist-induced platelet aggregation in platelet-rich plasma was enhanced in the patients with reocclusion. Decreased endogenous plasma TPA concentrations and enhanced platelet reactivity may contribute to the occurrence of reocclusion after primarily successful coronary artery recanalization.
Collapse
Affiliation(s)
- W Terres
- Department of Cardiology, Medical Clinic, University Hospital Eppendorf, Hamburg, Federal Republic of Germany
| | | | | | | | | | | |
Collapse
|
43
|
Bach D, van den Berg-Segers A, Hübner A, van Breukelen G, Cesana M, Plétan Y. Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis. J Urol 1995; 154:19-24. [PMID: 7776420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
PURPOSE We compare the bacteriological and clinical efficacy of rufloxacin and ciprofloxacin in patients with acute uncomplicated pyelonephritis. MATERIALS AND METHODS A total of 110 outpatients was enrolled in a randomized, double-blind multicenter study and treated for 10 days with 200 mg. rufloxacin daily (after a loading dose of 400 mg. on day 1) or 500 mg. ciprofloxacin twice daily. Bacteriological and clinical efficacy was based on the accumulated outcomes assessed at the end of treatment, and at 2 and 4 to 6 weeks. RESULTS The bacteriological and clinical success rates of rufloxacin and ciprofloxacin were comparable: 55.6% versus 58.8% and 74% versus 71%, respectively (95% confidence interval -28% to +22% and -20% to +25%, respectively). Both study medications were well tolerated. CONCLUSIONS Rufloxacin once daily is a good alternative in the outpatient treatment of acute uncomplicated pyelonephritis.
Collapse
Affiliation(s)
- D Bach
- Department of Urology, St. Agnes Hospital, Bocholt, Germany
| | | | | | | | | | | |
Collapse
|
44
|
Abstract
The in vitro fidelity of reverse transcriptase from human immunodeficiency virus type I (HIV-1 RT) upon copying an RNA template was measured using the phi Xam 16 reversion assay. A phi X174 sequence harboring the amber 16 codon was cloned into a transcription vector. RNA obtained from transcription by bacteriophage T7 RNA polymerase was used as a template for RNA-directed DNA synthesis by HIV-1 RT. An imbalance of dNTP concentrations during the reverse transcription step served to distinguish between errors that arose from the transcription step and errors from reverse transcription. The frequency of dGTP.U mismatches was determined to be 1/360, while dGTP.rA mismatches formed at a rate of 1/4600. These are 20-fold and sevenfold higher, respectively, than the error rates determined for the same sequence with a DNA template. Due to a high background of errors in the RNA template originating from the transcription step only upper limits for the frequency of three other mismatches can be given. The data indicate that the reverse transcription step of the HIV-1 replication cycle contributes significantly to the generation of mutant viruses.
Collapse
Affiliation(s)
- A Hübner
- Universität Bayreuth, Laboratorium für Biochemie, Germany
| | | | | | | |
Collapse
|
45
|
Schumacher GH, Hübner A, Pommerenke F. [What effect does the tongue have on mandibular growth?]. Phillip J Restaur Zahnmed 1988; 5:320-2. [PMID: 2856146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|
46
|
Abstract
Typical in MEA IIb is a combination of medullary carcinoma of the thyroid gland and a pheochromocytoma with neurocutaneous and skeletal anomalies and a hyperplasia of the sympathetic nervous system of the GI tract with megacolon. Two patients of a family with MEA II are described. The family history reveals 1) an autosomal inheritance with high penetrance, 2) a changing pattern of anomalies in different generations, 3) no marfanoid traits as typical in MEA IIb, 4) only males affected by megacolon. This may be an uncommon variation or an additional type: IIc. Further investigation is required.
Collapse
Affiliation(s)
- A Hübner
- Kinderklinik Riehl, Chirurgische Abteilung, Köln
| | | |
Collapse
|
47
|
Gülker H, Spyra W, Thale J, Krimphove F, Hübner A, Bender F. Assessment of the electrophysiologic, antiarrhythmic and haemodynamic profile of a new isoquinolinedione derivative. Arzneimittelforschung 1987; 37:917-9. [PMID: 3675686] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
The electrophysiological, antiarrhythmic and haemodynamic profile of a new isoquinolinedione derivative, 2,2'-[iminobis(trimethylene)]-di(4,4-dimethyl-1,3-(2H,4H)-isoqu inolinedione) hydrochloride (AR-03 Cl) was evaluated using dog models relevant to conditions in humans. In 16 animals dose-related effects on intercardiac conduction, ventricular refractoriness and on haemodynamic parameters were determined. In another 7 dogs antiarrhythmic actions of AR-03 Cl on delayed reperfusion arrhythmias following release of coronary artery occlusion after 2 h of obstruction were investigated. The results show: AR-03 Cl causes a significant prolongation in conduction through all parts of the conducting system. The AH-interval, HV-interval and QRS-duration are significantly lengthened. Ventricular repolarization is only slightly changed. There are no significant changes in heart rate, systolic and diastolic aortic pressure up to doses of 2 mg/kg b.w. However, left ventricular (dp/dtmax) and cardiac output are significantly reduced, and left ventricular enddiastolic pressure is increased. In acute myocardial necrosis delayed reperfusion arrhythmias are almost completely abolished, the effective dose is lower than that required with any other antiarrhythmic drug investigated so far in this particular experimental set-up. Further experimental and clinical testing of the new compound seems to be promising because of its strong dose-related antiarrhythmic potency. However, there is a need for further analysis of potential haemodynamic side effects of the new compound to establish the clinical significance of negative inotropic actions at therapeutic doses.
Collapse
Affiliation(s)
- H Gülker
- University Hospital, Department of Cardiology-Angiology, Münster/Westf., Fed. Rep. of Germany
| | | | | | | | | | | |
Collapse
|
48
|
Hübner A, Schöll W, Fischer S. [Passive immunoprophylaxis against coli dysentery of suckling pigs by vaccination of sows with attenuated Escherichia coli mutants. 1. Clinical and laboratory diagnostic results of the combined use of K88- and K99-antigen-containing strains derived from Escherichia coli mutants]. Arch Exp Veterinarmed 1983; 37:717-27. [PMID: 6362603] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
|
49
|
Hübner A, Buchmann K. [The importance of intra-abdominal adhesions for laparoscopy]. Z Gesamte Inn Med 1980; 35:255-257. [PMID: 6447416] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
The explorative laparoscopy has changed the attitude to certain contraindications. Concretions are of importance for the disposition of the penumoperitoneum and for the inspection. Their view is variable and is of importance only after larger intraabdominal interventions. In 218 laparoscopies performed we found 55 times concretions, of them important ones in three fourths. In 90% additional diagnostic points of view could be got.
Collapse
|
50
|
Hübner A, Dusold E. [Activity of the "Commission for the Scientific Use of Drugs" on the district level, as demonstrated on the Berlin-Lichtenberg urban district]. Dtsch Gesundheitsw 1972; 27:2305-9. [PMID: 4651185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|